Scientists say they have found a pattern of so-called epigenetic 'marks' in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may keep at least a ...
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...
Human-induced pluripotent stem cells (hiPSCs) have shown remarkable potential in various applications including cell therapy, regenerative medicine, and ...
UK: A recent study based on the UK Biobank cohort suggests that general obesity and diabetes may contribute to a higher risk ...
Optimizing gelatin hydrogels for volumetric 3D bioprinting. Insights from Rousselot’s Jos Olijve on the ENLIGHT bioprinting project.
Scientists have long been exploring ways to kill cancer cells by starving them of the nutrients they need to survive. A new ...
Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year's ...
Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many ...
Scientists in the US who do research on mRNA technology worry their funding may be cut under President Trump. mRNA technology is the basis for COVID- and other vaccines and could play a role in cancer ...
CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 985830 Nebraska Medical Center, Omaha, Nebraska 68198, United States Center for Drug Delivery and ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. Adding immunotherapy to a new type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results